文献速递创伤与烧伤重症综合管理与镇静镇痛

近期冲突中严重战伤后多器官衰竭:法国回顾性队列研究

MULTIPLE ORGAN FAILURE FOLLOWING SEVERE BATTLE INJURIES DURING RECENT CONFLICTS: A FRENCH RETROSPECTIVE COHORT STUDY.
PubMed 文献 · Shock · 2024-10-18
一句话结论法国回顾性队列显示,严重战伤后第4天持续多器官衰竭发生率为22%,严重损伤数量与其独立相关(OR 1.5)。

该回顾性研究纳入2009—2023年需入住ICU的法国陆军现役严重战伤伤员共100例,按序贯器官衰竭评估评分分析7天创伤病程中各器官衰竭情况。第4天持续存在多器官衰竭者(MOF组)占22%,其中位SOFA评分6.0[5.3-8.0];与非MOF组相比,MOF组损伤更严重(中位Military Injury Severity Score 38.0[33.0-56.8] vs 26.5[20.0-34.0],P<0.001)、爆炸致伤占68.2%、创伤性脑损伤更多(40.9% vs 14.1%,P=0.013)、输血单位更多(中位14.0[8.3-24.8] vs 6.0[0.0-12.0],P<0.001)、大量输血更多(68.2% vs 32.1%,P=0.002)。多因素logistic回归显示第4天持续MOF与严重损伤显著相关(OR 1.5[95%CI 1-2.3],P=0.042)。作者认为大量严重损伤显著且独立增加战伤后第4天持续MOF风险,对当前及预期的大规模作战行动中的战场伤员救治与后送具有意义。

要点

  • 严重战伤需ICU救治者中,第4天持续MOF占22%,中位SOFA评分6.0[5.3-8.0]。
  • MOF组损伤更严重:中位Military Injury Severity Score 38.0[33.0-56.8] vs 26.5[20.0-34.0],P<0.001。
  • MOF组爆炸致伤占68.2%,创伤性脑损伤40.9% vs 14.1%(P=0.013)。
  • MOF组输血更多:中位14.0[8.3-24.8] vs 6.0[0.0-12.0]单位(P<0.001),大量输血68.2% vs 32.1%(P=0.002)。
  • 多因素回归显示第4天持续MOF与严重损伤独立相关:OR 1.5[95%CI 1-2.3],P=0.042。

适用人群与场景

  • 2009—2023年期间所有需入住ICU的法国陆军现役严重战伤伤员。

诊断标准与关键阈值

  • 采用序贯器官衰竭评估评分,在7天创伤病程中分析各器官衰竭。
  • 第4天持续多器官衰竭定义为MOF组,占全部100例的22%,中位序贯器官衰竭评估评分6.0[5.3-8.0]。

红旗征与不能漏的情况

  • 爆炸致伤(MOF组占68.2%)、合并创伤性脑损伤(MOF组40.9% vs 非MOF组14.1%,P=0.013)、需要大量输血(MOF组68.2% vs 非MOF组32.1%,P=0.002)的严重战伤伤员,第4天持续MOF风险更高。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量100例;人群:2009—2023年需入住ICU的法国陆军现役严重战伤伤员。
  • 第4天持续MOF(MOF组)占22%,中位序贯器官衰竭评估评分6.0[5.3-8.0]。
  • MOF组 vs 非MOF组:中位Military Injury Severity Score 38.0[33.0-56.8] vs 26.5[20.0-34.0],P<0.001。
  • MOF组爆炸致伤占68.2%;创伤性脑损伤40.9% vs 14.1%,P=0.013。
  • MOF组输血单位中位14.0[8.3-24.8] vs 6.0[0.0-12.0],P<0.001;大量输血68.2% vs 32.1%,P=0.002。
  • 肺和心血管功能障碍是最常见的创伤结局。
  • 多因素logistic回归模型显示,第4天持续MOF与严重损伤显著相关:OR 1.5[95%CI 1-2.3],P=0.042。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,大量严重损伤显著且独立增加战伤后第4天持续MOF风险,这些发现对当前及预期的大规模作战行动中的战场伤员救治与后送具有意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction : Improvements in combat casualty care have increased survival rates, but these patients are at particular risk of developing multiple organ failure (MOF). We investigated the incidence and severity of MOF in a cohort of severe combat casualties. Materials and Methods : This retrospective study included all on-duty French land army war casualties with a severe combat injury requiring intensive care unit admission during 2009-2023. Demographic data, advanced life support interventions, and outcomes were collected. Each organ failure was then analyzed during a 7-day trauma course according to the Sequential Organ Failure Assessment score. Results: Of the 100 patients who met the inclusion criteria, those with persistent MOF at day 4 (MOF group) represented 22% of the total population (median Sequential Organ Failure Assessment score 6.0 [5.3-8.0]). Compared to those without persistent MOF, these patients were more severely injured (median Military Injury Severity Score 38.0 [interquartile range 33.0-56.8] vs. 26.5 [20.0-34.0], P < 0.001) by an explosive mechanism (68.2%) and sustained more traumatic brain injury (40.9% vs. 14.1%, P = 0.013). The MOF group also received significantly more blood units (median 14.0 [8.3-24.8] vs. 6.0 [0.0-12.0], P < 0.001) and massive transfusions (68.2% vs. 32.1%, P = 0.002). Pulmonary and cardiovascular dysfunction were the most frequently observed trauma outcomes. A multivariable logistic regression model showed that MOF persistence at day 4 was significantly associated (odds ratios [95% confidence intervals]) with severe injuries (1.5 [1-2.3], P = 0.042). Conclusion : A high number of severe lesions significantly and independently increased risk of MOF persistence at day 4 after combat-related trauma. These findings are particularly relevant to current and anticipated large-scale combat operations that will challenge battlefield casualty care and evacuation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Schmitt J, Jacques Sébastien C, Herzog N, et al. MULTIPLE ORGAN FAILURE FOLLOWING SEVERE BATTLE INJURIES DURING RECENT CONFLICTS: A FRENCH RETROSPECTIVE COHORT STUDY. Shock. 2024. PMID: 39454634. doi:10.1097/SHK.0000000000002497

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。